New scan could sharpen view of rectal cancer during treatment
NCT ID NCT05245786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a special PET scan that uses a radioactive tracer (64Cu-M5A) to highlight rectal cancer cells. The goal is to see if this scan can show tumor extent and response more accurately than standard imaging before and after chemotherapy and radiation. About 14 adults with locally advanced rectal cancer will participate. The study focuses on improving detection, not on treating the disease directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common muscle relaxant make radiation deadlier for rectal cancer?
- New combo aims to spare rectal cancer patients from surgery
- Intermittent fasting tested to ease radiation side effects in cancer patients
- New combo immunotherapy aims to shrink colon tumors before surgery
- New adaptive radiation boosts rectal cancer response rates
- New app aims to help cancer survivors and families stick to healthy habits